Interestingly, the PNPLA3 GG genotype nullified the effect of lifestyle and emerged as an independent risk factor for weight gain, opening new perspectives in NAFLD patient care. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.